127 related articles for article (PubMed ID: 1173986)
1. 131I-19-iodocholesterol scintigraphy of the adrenal cortex.
Dige-Petersen H; Munkner T; Fogh J; Blichert-Toft M; Lund JO
Acta Endocrinol (Copenh); 1975 Sep; 80(1):81-94. PubMed ID: 1173986
[TBL] [Abstract][Full Text] [Related]
2. Scintigraphy with 131I-19-iodocholesterol in adrenal disease.
Jorgensen H; Norman N; Sundsfjord JA
Acta Med Scand; 1975 May; 197(5):345-51. PubMed ID: 1146612
[TBL] [Abstract][Full Text] [Related]
3. Adrenal scintigraphy with 131I-19-iodochlesterol in the diagnosis of Cushing's syndrome associated with adrenal tumor.
Barliev GB
Eur J Nucl Med; 1979 Dec; 4(6):449-51. PubMed ID: 520360
[TBL] [Abstract][Full Text] [Related]
4. [Nuclear medicine diagnostic localization in primary aldosteronism and Cushing syndrome].
Sialer G; Marincek B; Mengden T; Vetter W
Bildgebung; 1987-1989; 56(4):157-62. PubMed ID: 3078253
[TBL] [Abstract][Full Text] [Related]
5. [Adrenocortical scintigraphy with 131I-19-iodocholesterol. Indications and results in 66 cases of hypercortisolism and hyperaldosteronism (author's transl)].
Leger FA; Requeda E; Reach G; Plouin PF; Savoie JC
Nouv Presse Med; 1981 Feb; 10(6):395-9. PubMed ID: 7220332
[TBL] [Abstract][Full Text] [Related]
6. 131I-iodocholesterol (NP-59) scintigraphy in adrenocortical diseases.
Taillefer R; Soucy JP; Eybalin MC; Levasseur A
J Can Assoc Radiol; 1983 Jun; 34(2):120-4. PubMed ID: 6885882
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of adrenal venography and iodocholesterol scan in adrenal surgery.
Herwig KR; Sonda LP
J Urol; 1979 Jul; 122(1):7-8. PubMed ID: 458994
[TBL] [Abstract][Full Text] [Related]
8. 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas.
Bardet S; Rohmer V; Murat A; Guillemot C; Maréchaud R; Chupin M; Lecomte P; Simon D; Delemer B; Schneebelli S; Beutter D; Jacquin V; Peltier P; Charbonnel B
Clin Endocrinol (Oxf); 1996 May; 44(5):587-96. PubMed ID: 8762736
[TBL] [Abstract][Full Text] [Related]
9. The diagnosis of Cushing's syndrome using 131I-19-iodocholesterol uptake and adrenal imaging.
Ortega D; Foz M; Doménech-Torné FM; Tresánchez JM
Clin Endocrinol (Oxf); 1980 Aug; 13(2):145-9. PubMed ID: 7438469
[TBL] [Abstract][Full Text] [Related]
10. Adrenal scintigraphy in primary aldosteronism. Improved visualization after long-term pre-treatment with dexamethasone.
Hoefnagels WH; Claessens RA; Corstens FH; Drayer JI; Kazem I; Kloppenborg PW
Nuklearmedizin; 1981 Apr; 20(2):76-81. PubMed ID: 7243603
[TBL] [Abstract][Full Text] [Related]
11. Adrenal scintigraphy in Cushing's syndrome caused by bilateral hyperplasia, adenoma or carcinoma.
Lindberg S; Ernest I; Fjälling M; Holmdahl C
Nucl Med Commun; 1985 Jan; 6(1):31-6. PubMed ID: 3039430
[TBL] [Abstract][Full Text] [Related]
12. [Adrenal cortex scintigraphy with and without dexamethasone suppression in the study of primary aldosteronism].
Milà López M; Castell-Conesa J; Pifarré Montaner P; Lorenzo Bosquet C; García-Burillo A; Porta Biosca F; Roca Bielsa I
Rev Esp Med Nucl; 2004; 23(5):324-9. PubMed ID: 15450137
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol.
Reschini E; Catania A
Eur J Nucl Med; 1991; 18(10):817-23. PubMed ID: 1743205
[TBL] [Abstract][Full Text] [Related]
14. Adrenal imaging with 131I-19-iodocholesterol in the diagnostic evaluation of patients with aldosteronism.
Seabold JE; Cohen EL; Beierwaltes WH; Hinerman DL; Nishiyama RH; Bookstein JJ; Ice RD; Balachandran S
J Clin Endocrinol Metab; 1976 Jan; 42(1):41-51. PubMed ID: 1249193
[TBL] [Abstract][Full Text] [Related]
15. Uptake ratio of (19-1311) cholesterol by adrenal glands as observed by a scintigraphic method.
Nakamura M; Sawai Y; Fukuchi S; Nakajima K; Abe M
Tohoku J Exp Med; 1975 Jun; 116(2):191-9. PubMed ID: 1154387
[TBL] [Abstract][Full Text] [Related]
16. Adrenal scintigraphy in the morphological and functional evaluation of Cushing's syndrome.
Bui F; Macri' C; Varotto L; Boscaro M; Mantero F
Cardiology; 1985; 72 Suppl 1():76-83. PubMed ID: 2996768
[TBL] [Abstract][Full Text] [Related]
17. Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome.
Fig LM; Gross MD; Shapiro B; Ehrmann DA; Freitas JE; Schteingart DE; Glazer GM; Francis IR
Ann Intern Med; 1988 Oct; 109(7):547-53. PubMed ID: 3421563
[TBL] [Abstract][Full Text] [Related]
18. [Photoscintigraphy of adrenal glands using 131I-cholesterol in patients with primary aldosteronism and Cushing's syndrome].
Jørgensen H; Norman N; Sundsfjord JA
Tidsskr Nor Laegeforen; 1975 Jan; 95(1):9-12. PubMed ID: 1111168
[No Abstract] [Full Text] [Related]
19. Radioisotopic study of the adrenal glands using 131I-19-iodocholesterol.
Troncone L; Galli G; Salvo D; Barbarino A; Bonomo L
Br J Radiol; 1977 May; 50(593):340-9. PubMed ID: 861453
[TBL] [Abstract][Full Text] [Related]
20. Limited significance of asymmetric adrenal visualization on dexamethasone-suppression scintigraphy.
Gross MD; Shapiro B; Freitas JE
J Nucl Med; 1985 Jan; 26(1):43-8. PubMed ID: 2981301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
